Skip to main content

Fifth Third Bancorp

SEC CIK
0000035527
Latest filing
Aug 5, 2026

BMRN holding history

Biomarin Pharmaceutical Inc in every 13F filed by Fifth Third Bancorp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

BMRN overviewAll 13F holders of BMRNFull Q2 2026 holdings

Shares (Q2 2026)
48,844
Value
$2.79M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of BMRN by Fifth Third Bancorp, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202648,844$2.79M<0.1%−14,147−22.5%ReducedHolders
Q1 202662,991$3.56M<0.1%+62,183+7,695.9%AddedHolders
Q4 2025808$48.0K<0.1%−584−42.0%ReducedHolders
Q3 20251,392$75.4K<0.1%−212−13.2%ReducedHolders
Q2 20251,604$88.2K<0.1%−777−32.6%ReducedHolders
Q1 20252,381$168.3K<0.1%+1,030+76.2%AddedHolders
Q4 20241,351$88.8K<0.1%+165+13.9%AddedHolders
Q3 20241,186$83.4K<0.1%−350−22.8%ReducedHolders
Q2 20241,536$126.5K<0.1%+1,352+734.8%AddedHolders
Q1 2024184$16.1K<0.1%−41−18.2%ReducedHolders
Q4 2023225$21.7K<0.1%−1,759−88.7%ReducedHolders
Q3 20231,984$175.5K<0.1%+1,691+577.1%AddedHolders
Q2 2023293$25.4K<0.1%+52+21.6%AddedHolders
Q1 2023241$23.4K<0.1%+64+36.2%AddedHolders
Q4 2022177$18.3K<0.1%+158+831.6%AddedHolders
Q3 202219$2.00K<0.1%−238−92.6%ReducedHolders
Q2 2022257$21.0K<0.1%+238+1,252.6%AddedHolders
Q1 202219$1.00K<0.1%−5−20.8%ReducedHolders
Q4 202124$2.00K<0.1%−43−64.2%ReducedHolders
Q3 202167$5.00K<0.1%+7+11.7%AddedHolders
Q2 202160$5.00K<0.1%−1−1.6%ReducedHolders
Q1 202161$5.00K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.